Michael Crowley's most recent trade in Lamb Weston Holdings Inc was a trade of 57 Common Stock done at an average price of $54.7 . Disclosure was reported to the exchange on April 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lamb Weston | Michael Christopher Crowley | President, North America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.74 per share. | 11 Apr 2025 | 57 | 4,758 (0%) | 0% | 54.7 | 3,120 | Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 13,828 | 42,302 | - | 0 | Class A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 14 Mar 2025 | 3,000 | 11,171 (0%) | 0% | 159.3 | 477,960 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 247.06 per share. | 14 Mar 2025 | 3,000 | 8,171 (0%) | 0% | 247.1 | 741,184 | Bio-Rad A Common Stock |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 8,207 | 10,947 (0%) | 0% | 0 | Class A Common | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.77 per share. | 01 Mar 2025 | 170 | 2,740 (0%) | 0% | 243.8 | 41,441 | Class A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,456 | 3,456 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 7,324 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 2,254 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 8,454 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 1,042 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 7,576 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 8,052 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 406 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 7,763 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 283 | 8,171 (0%) | 0% | 334.3 | 94,610 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 268 | 7,056 (0%) | 0% | 337.3 | 90,402 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 218 | 7,358 (0%) | 0% | 337.3 | 73,536 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 155 | 7,897 (0%) | 0% | 337.3 | 52,285 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 145 | 7,618 (0%) | 0% | 337.3 | 48,911 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 281.91 per share. | 13 Jun 2024 | 369 | 6,573 (0%) | 0% | 281.9 | 104,023 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | 01 Apr 2024 | 9,836 | 28,474 | - | 0 | Class A Common Stock | ||
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,348 | 2,910 (0%) | 0% | 0 | Class A Common | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.14 per share. | 01 Mar 2024 | 152 | 1,562 (0%) | 0% | 308.1 | 46,837 | Class A Common Stock |
| Bio-Rad Laboratories Inc. ... | Crowley Michael | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 336.00 per share. | 27 Feb 2024 | 3,000 | 6,942 (0%) | 0% | 336 | 1,008,000 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Crowley Michael | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 27 Feb 2024 | 3,000 | 9,942 (0%) | 0% | 216.0 | 647,940 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 305.10 per share. | 28 Nov 2023 | 642 | 6,942 (0%) | 0% | 305.1 | 195,874 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 7,882 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 557 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 7,484 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 6,560 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 7,077 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 6,785 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 298 | 7,584 (0%) | 0% | 394.6 | 117,591 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 202 | 7,282 (0%) | 0% | 394.6 | 79,709 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 6,380 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 6,927 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 6,644 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 379.39 per share. | 15 Jun 2023 | 500 | 6,040 (0%) | 0% | 379.4 | 189,695 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | 01 Apr 2023 | 10,297 | 18,638 | - | 0 | Class A Common Stock | ||
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,838 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,536 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 6,177 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 1,114 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 5,770 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 867 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,540 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,238 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 241 | 5,936 (0%) | 0% | 478.3 | 115,275 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 150 | 5,620 (0%) | 0% | 478.3 | 71,748 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,216 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 5,478 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 141 | 5,337 (0%) | 0% | 486.2 | 68,561 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | 01 Apr 2022 | 8,341 | 8,341 | - | 0 | Class A Common Stock | ||
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 5,371 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 806.32 per share. | 07 Sep 2021 | 298 | 5,073 (0%) | 0% | 806.3 | 240,283 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 1,200 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 5,069 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 4,767 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 1,671 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 4,444 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 4,771 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 4,469 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 277 | 4,167 (0%) | 0% | 819.7 | 227,057 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 1,300 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 4,102 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 01 Sep 2021 | 215 | 3,887 (0%) | 0% | 825.8 | 177,541 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.56 per share. | 09 Aug 2021 | 3,000 | 6,669 (0%) | 0% | 139.6 | 418,680 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 754.80 per share. | 09 Aug 2021 | 2,570 | 4,099 (0%) | 0% | 754.8 | 1,939,836 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 755.72 per share. | 09 Aug 2021 | 430 | 3,669 (0%) | 0% | 755.7 | 324,960 | Bio-Rad A Common Stock |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 22.92 per share. | 15 Mar 2021 | 52 | 732,102 (0%) | 0% | 22.9 | 1,192 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 22.92 per share. | 15 Mar 2021 | 40 | 732,050 (0%) | 0% | 22.9 | 917 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 18.06 per share. | 01 Feb 2021 | 6,644 | 728,717 (0%) | 0% | 18.1 | 119,991 | Common Stock $0.01 Par Value |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 580.67 per share. | 15 Dec 2020 | 374 | 3,669 (0%) | 0% | 580.7 | 217,171 | Bio-Rad A Common Stock |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 15 Dec 2020 | 67 | 722,073 (0%) | 0% | 16.8 | 1,125 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 16.78 per share. | 15 Dec 2020 | 55 | 722,006 (0%) | 0% | 16.8 | 923 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 13.27 per share. | 15 Sep 2020 | 83 | 721,883 (0%) | 0% | 13.3 | 1,101 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 13.26 per share. | 15 Sep 2020 | 68 | 721,951 (0%) | 0% | 13.3 | 902 | Common Stock $0.01 Par Value |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 4,341 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.02 per share. | 11 Sep 2020 | 298 | 4,043 (0%) | 0% | 505.0 | 150,496 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 1,200 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 3,273 (0%) | 0% | 0 | Bio-Rad A Common Stock |